Sanofi to acquire Synthorx for $2.5B
Sanofi will acquire clinical-stage biotechnology company, Synthorx, for approximately $2.5 billion.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news
More News: Biotechnology | Pharmaceuticals